Literature DB >> 23282118

Analysis of recent papers in hypertension: nighttime administration of at least one antihypertensive medication is associated with better blood pressure control and cardiovascular outcomes in patients with type 2 diabetes or chronic kidney disease.

Jan N Basile1, Michael J Bloch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23282118      PMCID: PMC8108246          DOI: 10.1111/jch.12028

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  2 in total

1.  Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD.

Authors:  Ramón C Hermida; Diana E Ayala; Artemio Mojón; José R Fernández
Journal:  J Am Soc Nephrol       Date:  2011-10-24       Impact factor: 10.121

2.  Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes.

Authors:  Ramón C Hermida; Diana E Ayala; Artemio Mojón; José R Fernández
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

  2 in total
  4 in total

Review 1.  Chronotherapy for hypertension in patients with chronic kidney disease: a systematic review and meta-analysis in non-black patients.

Authors:  Caixia Wang; Xilian Qiu; Linsheng Lv; Jianhua Huang; Shaomin Li; Tanqi Lou; Xun Liu
Journal:  Int Urol Nephrol       Date:  2016-11-14       Impact factor: 2.370

2.  Hypertension.

Authors:  James Brian Byrd; Robert D Brook
Journal:  Ann Intern Med       Date:  2019-05-07       Impact factor: 25.391

3.  Ethical complexities in standard of care randomized trials: A case study of morning versus nighttime dosing of blood pressure drugs.

Authors:  Scott Y H Kim; Franklin G Miller
Journal:  Clin Trials       Date:  2015-09-22       Impact factor: 2.486

Review 4.  Efficacy and safety of nighttime dosing of antihypertensives: review of the literature and design of a pragmatic clinical trial.

Authors:  Barry L Carter; Elizabeth A Chrischilles; Gary Rosenthal; Brian M Gryzlak; Eric L Eisenstein; Mark W Vander Weg
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-12-24       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.